Azithromycin
NDC Package 55695-006-00

11-digit billing NDC: 55695000600

Package Information

This product is EXCLUDED from the official NDC directory because the listing data was inactivated by the FDA.

Azithromycin is to reduce the development of drug-resistant bacteria and maintain the effectiveness of AZITHROMYCIN and other antibacterial drugs, AZITHROMYCIN should be used only to treat infections that are proven or strongly suspected to be caused by susceptible bacteria. Marketed by Department Of State Health Services, Pharmacy Branch, this product is identified by NDC 55695-006 and is authorized under FDA application NDA050711.

Identification & Billing

NDC Package Code
55695-006-00
Package Description
30 TABLET, FILM COATED in 1 BOTTLE
Product Code
11-Digit Billing Format
55695000600
RxNorm Crosswalk

Clinical Specifications

Proprietary Name
Azithromycin
Dosage Form
-
Usage Information
To reduce the development of drug-resistant bacteria and maintain the effectiveness of AZITHROMYCIN and other antibacterial drugs, AZITHROMYCIN should be used only to treat infections that are proven or strongly suspected to be caused by susceptible bacteria. When culture and susceptibility information are available, they should be considered in selecting or modifying antibacterial therapy. In the absence of such data, local epidemiology and susceptibility patterns may contribute to the empiric selection of therapy.AZITHROMYCIN is a macrolide antibacterial drug indicated for the treatment of patients with mild to moderate infections caused by susceptible strains of the designated microorganisms in the specific conditions listed below. Recommended dosages and durations of therapy in adult and pediatric patient populations vary in these indications. [see Dosage and Administration (2)]

Regulatory & Marketing

Labeler Name
Department Of State Health Services, Pharmacy Branch
FDA Application #
NDA050711
Marketing Category
NDA AUTHORIZED GENERIC - A product marketed as a "generic" drug under an approved New Drug Application (NDA), rather than an Abbreviated New Drug Application (ANDA),.
Start Marketing Date
07-18-1996
Listing Expiration
12-31-2018
Exclude Flag
I
Sample Package
No

Hierarchy Structure

Code Lineage

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 55695-006-00 identifies a specific commercial package of 30 tablet, film coated in 1 bottle of Azithromycin, labeled by Department Of State Health Services, Pharmacy Branch. This is formulated for use and contains as the active substance.

Is this product currently listed with the FDA?

This product code is currently listed as inactive or excluded from the primary directory. It was introduced to the market by Department Of State Health Services, Pharmacy Branch on July 18, 1996. The current certification is valid through December 31, 2018.

How is this Department Of State Health Services, Pharmacy Branch product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 55695000600. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (5-3-2)
55695-006-00
11-Digit CMS (5-4-2)
55695-0006-00

Note: The zero is added to the Product segment to maintain the 5-4-2 structure.